Moderna, Inc. (MRNA)
USD 24.19
(-3.68%)
USD 24.19
(-3.68%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 6.39 Billion USD | 42.31% |
| 2022 | 4.42 Billion USD | 142.84% |
| 2021 | 1.82 Billion USD | 77.04% |
| 2020 | 1.02 Billion USD | 73.42% |
| 2019 | 593.75 Million USD | 10.82% |
| 2018 | 535.77 Million USD | 20.04% |
| 2017 | 446.33 Million USD | 37.2% |
| 2016 | 325.3 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.3 Billion USD | -30.72% |
| 2024 Q2 | 1.44 Billion USD | 11.3% |
| 2023 Q4 | 1.87 Billion USD | 17.23% |
| 2023 FY | 6.3 Billion USD | 42.31% |
| 2023 Q2 | 1.48 Billion USD | 3.06% |
| 2023 Q3 | 1.6 Billion USD | 8.24% |
| 2023 Q1 | 1.43 Billion USD | -9.46% |
| 2022 Q2 | 738 Million USD | 6.03% |
| 2022 Q4 | 1.58 Billion USD | 66.25% |
| 2022 FY | 4.42 Billion USD | 142.84% |
| 2022 Q1 | 696 Million USD | 18.57% |
| 2022 Q3 | 954 Million USD | 29.27% |
| 2021 Q1 | 284 Million USD | -42.8% |
| 2021 FY | 1.82 Billion USD | 77.04% |
| 2021 Q4 | 587 Million USD | 6.92% |
| 2021 Q3 | 549 Million USD | 36.23% |
| 2021 Q2 | 403 Million USD | 41.9% |
| 2020 FY | 1.02 Billion USD | 73.42% |
| 2020 Q3 | 247.33 Million USD | 64.27% |
| 2020 Q4 | 496.48 Million USD | 100.73% |
| 2020 Q1 | 135.31 Million USD | -4.1% |
| 2020 Q2 | 150.56 Million USD | 11.27% |
| 2019 Q1 | 155.94 Million USD | -16.09% |
| 2019 Q4 | 141.1 Million USD | -2.14% |
| 2019 Q3 | 144.19 Million USD | -6.35% |
| 2019 Q2 | 153.96 Million USD | -1.27% |
| 2019 FY | 593.75 Million USD | 10.82% |
| 2018 Q3 | 122.48 Million USD | -0.3% |
| 2018 Q1 | 104.86 Million USD | -19.49% |
| 2018 FY | 535.77 Million USD | 20.04% |
| 2018 Q4 | 185.84 Million USD | 51.74% |
| 2018 Q2 | 122.84 Million USD | 17.15% |
| 2017 Q4 | 130.24 Million USD | 634.76% |
| 2017 Q3 | 17.72 Million USD | 8.11% |
| 2017 Q2 | 16.39 Million USD | 0.0% |
| 2017 Q1 | 16.39 Million USD | 0.0% |
| 2017 FY | 446.33 Million USD | 37.2% |
| 2016 FY | 325.3 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -2223.131% |
| Alkermes plc | 996.24 Million USD | -541.809% |
| Agenus Inc. | 78.18 Million USD | -8078.248% |
| Aptorum Group Limited | 10.56 Thousand USD | -60514758.982% |
| Ardelyx, Inc. | 169.93 Million USD | -3662.571% |
| Dyadic International, Inc. | 9.15 Million USD | -69759.198% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -28633.205% |
| Lantern Pharma Inc. | 17.87 Million USD | -35665.487% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -94879.994% |
| Novavax, Inc. | 779.12 Million USD | -720.664% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -7787.79% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -7678.967% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -32827.336% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -21496.974% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -11935.452% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -1580.438% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -26205.604% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -16784.523% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -20679.305% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -7447.571% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -36527.141% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -3696.101% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -19444.551% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -3901.577% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | -255.21% |
| AlloVir, Inc. | 180.93 Million USD | -3433.905% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -1334.478% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -21441.675% |
| Bicycle Therapeutics plc | 216.92 Million USD | -2847.603% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -3619.561% |
| ChromaDex Corporation | 56.37 Million USD | -11241.102% |
| Chimerix, Inc. | 93.38 Million USD | -6746.631% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -45868.117% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -4147.489% |
| CRISPR Therapeutics AG | 463.49 Million USD | -1279.522% |
| Precision BioSciences, Inc. | 92.46 Million USD | -6815.199% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -2416.887% |
| Fortress Biotech, Inc. | 200.19 Million USD | -3093.886% |
| Fortress Biotech, Inc. | 200.19 Million USD | -3093.886% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -19426.049% |
| ImmuCell Corporation | 9.61 Million USD | -66383.928% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -3951.605% |
| Immix Biopharma, Inc. | 16.14 Million USD | -39513.13% |
| Incyte Corporation | 1.19 Billion USD | -437.088% |
| Innoviva, Inc. | 132.15 Million USD | -4738.295% |
| IO Biotech, Inc. | 91.44 Million USD | -6892.334% |
| Jaguar Health, Inc. | 42.01 Million USD | -15118.374% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -3677.241% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -7482.747% |
| ContextLogic Inc. | 387 Million USD | -1552.196% |
| MiMedx Group, Inc. | 229.72 Million USD | -2683.304% |
| MEI Pharma, Inc. | 34.78 Million USD | -18281.486% |
| NextCure, Inc. | 67.63 Million USD | -9353.406% |
| Onconetix, Inc. | 34.9 Million USD | -18217.017% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -50064.758% |
| Opthea Limited | 191.96 Million USD | -3230.774% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -232275.158% |
| Vaxcyte, Inc. | 468.04 Million USD | -1266.12% |
| PDS Biotechnology Corporation | 43.04 Million USD | -14754.142% |
| Precigen, Inc. | 84.18 Million USD | -7495.538% |
| Pharming Group N.V. | 225.49 Million USD | -2735.59% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -3709.876% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -8711.289% |
| PureTech Health plc | 144.59 Million USD | -4321.945% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -4808.531% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -2508.114% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -26205.604% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -2696.047% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -20620.049% |
| Acelyrin, Inc. | 422.06 Million USD | -1414.936% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -49588856.104% |
| Summit Therapeutics Inc. | 87.68 Million USD | -7191.928% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -17151.241% |
| Senti Biosciences, Inc. | 94.7 Million USD | -6651.491% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -5075.107% |
| Elevation Oncology, Inc. | 45.44 Million USD | -13969.755% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -21597.377% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -162099.953% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -4737.526% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -18658.985% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -75559.685% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -3426.732% |
| Seer, Inc. | 110.49 Million USD | -5686.949% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -8957.427% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -6740.112% |
| ESSA Pharma Inc. | 32.13 Million USD | -19797.863% |
| GlycoMimetics, Inc. | 39.28 Million USD | -16175.811% |
| GT Biopharma, Inc. | 13.57 Million USD | -46997.82% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -2808.611% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -3079.276% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -2364.682% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -11165.174% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -11723.225% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -64241.2% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -1484.387% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -33678.858% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -12513.181% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -2362.46% |
| Aptose Biosciences Inc. | 52.35 Million USD | -12112.545% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -44270.812% |
| Soligenix, Inc. | 7.79 Million USD | -81924.299% |
| Century Therapeutics, Inc. | 56.07 Million USD | -11303.399% |
| Kura Oncology, Inc. | 165.8 Million USD | -3756.361% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -5483.938% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -76760.2% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -257552.302% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -5836.972% |
| Autolus Therapeutics plc | 196.72 Million USD | -3150.206% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -7452.831% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -5390.627% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -32887.67% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -1887.208% |
| GRI Bio, Inc. | 11.33 Million USD | -56334.245% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -90521.754% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -4773.736% |
| IGM Biosciences, Inc. | 265.59 Million USD | -2307.461% |
| INmune Bio, Inc. | 29.89 Million USD | -21287.477% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -3605.507% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -15760.373% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -39914.116% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -40518.61% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -10196.628% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -5846.69% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -2219.246% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -2021.074% |
| Verastem, Inc. | 92.08 Million USD | -6843.66% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -35543.01% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -3342.724% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -5166.583% |
| Histogen Inc. | 14.27 Million USD | -44701.009% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -39742.619% |
| Surrozen, Inc. | 18.55 Million USD | -34369.003% |
| Organovo Holdings, Inc. | 14.91 Million USD | -42769.594% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -125513.036% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -10615.035% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -24830.791% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -13502.519% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -83669.573% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -3489.392% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -13097.668% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -2509.753% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -41509.795% |
| Apollomics, Inc. | 54.14 Million USD | -11710.122% |
| Amarin Corporation plc | 272.35 Million USD | -2247.654% |
| Mesoblast Limited | 5.9 Million USD | -108236.157% |
| Turnstone Biologics Corp. | 78.33 Million USD | -8062.067% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -2519.182% |
| Synaptogenix, Inc. | 8.31 Million USD | -76807.773% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -43736.556% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -2426.713% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -19083.875% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -72302.105% |
| Exelixis, Inc. | 1.58 Billion USD | -302.955% |
| Better Therapeutics, Inc. | 38.26 Million USD | -16611.097% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -2655.441% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -647.66% |
| NLS Pharmaceutics AG | 11.8 Million USD | -54054.026% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -79408.515% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -21218.308% |
| Gritstone bio, Inc. | 148.37 Million USD | -4209.38% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -9185.372% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -38982.609% |
| Avid Bioservices, Inc. | 25.99 Million USD | -24496.092% |
| Insmed Incorporated | 949.26 Million USD | -573.577% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -40652.622% |
| MediWound Ltd. | 18.86 Million USD | -33788.064% |
| OmniAb, Inc. | 83.89 Million USD | -7521.432% |
| Alector, Inc. | 248.8 Million USD | -2469.915% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -2628.887% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -12137.086% |
| Zai Lab Limited | 547.47 Million USD | -1067.905% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -1503.897% |
| Aura Biosciences, Inc. | 84.99 Million USD | -7423.15% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -2487.218% |
| Immunic, Inc. | 99.22 Million USD | -6344.07% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -3921.08% |
| Veracyte, Inc. | 357.93 Million USD | -1686.368% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 29.08% |
| FibroGen, Inc. | 398.11 Million USD | -1506.077% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -44896.481% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -92728.821% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -89631.132% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | -96.399% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -24613.021% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -1919.947% |
| TG Therapeutics, Inc. | 198.47 Million USD | -3121.564% |
| Galecto, Inc. | 35.62 Million USD | -17847.063% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -15614.321% |
| Fortrea Holdings Inc. | 457.3 Million USD | -1298.207% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -11680.095% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -22041.423% |
| XBiotech Inc. | 37.51 Million USD | -16946.121% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -9185.372% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -30865.18% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -4400.883% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -6353.697% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -5675.136% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -567.259% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -22066.753% |
| Vaxxinity, Inc. | 56.05 Million USD | -11307.468% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -1384.767% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -28561.961% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -5667.271% |
| NexImmune, Inc. | 28.16 Million USD | -22599.912% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -115504.052% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -35635.621% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | -127.116% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -25014.891% |
| Scopus BioPharma Inc. | 11.71 Million USD | -54480.172% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -4932.189% |
| Ainos, Inc. | 12.95 Million USD | -49264.366% |
| Pluri Inc. | 22.48 Million USD | -28343.06% |
| Prothena Corporation plc | 282.4 Million USD | -2164.116% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -3096.648% |
| Celularity Inc. | 215.05 Million USD | -2873.151% |
| Rallybio Corporation | 78.93 Million USD | -8000.644% |
| Cue Biopharma, Inc. | 19.54 Million USD | -32619.271% |
| MeiraGTx Holdings plc | 151.07 Million USD | -4132.251% |
| Omeros Corporation | 94.75 Million USD | -6648.214% |
| Humacyte, Inc. | 23.49 Million USD | -27111.985% |
| Immunocore Holdings plc | 308.04 Million USD | -1975.704% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -188513.569% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -7260.847% |
| Blueprint Medicines Corporation | 722.86 Million USD | -784.541% |
| CalciMedica, Inc. | 21.81 Million USD | -29207.421% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -8464.158% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -3882.808% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -3632.742% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -2067.899% |
| Pulmatrix, Inc. | 22.03 Million USD | -28913.522% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -18393.131% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -7095.103% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -1059.245% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -8713.111% |
| Cytokinetics, Incorporated | 173.61 Million USD | -3582.925% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -18476.949% |
| Nutriband Inc. | 5.73 Million USD | -111409.687% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -14560.766% |
| Vor Biopharma Inc. | 126.03 Million USD | -4973.154% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -437.682% |
| Evogene Ltd. | 27.79 Million USD | -22908.276% |
| ProKidney Corp. | 151.52 Million USD | -4119.849% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -8520.155% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -83022.71% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -940.983% |
| CorMedix Inc. | 48.95 Million USD | -12960.231% |
| BioLineRx Ltd. | 50.8 Million USD | -12486.119% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -4142.867% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -16694.495% |
| Atai Life Sciences N.V. | 125.78 Million USD | -4983.277% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -7732.013% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -7754.168% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -2431.756% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -19429.627% |
| MediciNova, Inc. | 10.9 Million USD | -58559.124% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -4863.515% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -87977.4% |
| GeoVax Labs, Inc. | 6.02 Million USD | -106074.3% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -1242.262% |
| Biomea Fusion, Inc. | 126.13 Million USD | -4969.172% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | -387.408% |
| Mereo BioPharma Group plc | 35.84 Million USD | -17739.406% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -3246.085% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -2680.556% |
| Absci Corporation | 73.66 Million USD | -8579.717% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -23081.785% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -4686.286% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -2540.381% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -2340.011% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -2974.127% |
| Allakos Inc. | 196.05 Million USD | -3161.313% |
| Imunon, Inc. | 20.31 Million USD | -31381.37% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -5535.019% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -1634.615% |
| BioAtla, Inc. | 129.68 Million USD | -4830.332% |
| NLS Pharmaceutics AG | 11.8 Million USD | -54054.026% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -40258.518% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -7429.617% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -15212.036% |
| XOMA Corporation | 46.46 Million USD | -13661.488% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -5651.5% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -4388.183% |
| aTyr Pharma, Inc. | 12.97 Million USD | -49164.196% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -6068.48% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -3598.733% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -2409.774% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -16992.601% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -77640.36% |
| Akari Therapeutics, Plc | 16.8 Million USD | -37945.936% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -281082.25% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -2036.19% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -94925.361% |
| UroGen Pharma Ltd. | 138.88 Million USD | -4503.709% |
| Sutro Biopharma, Inc. | 243 Million USD | -2531.178% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -87794.601% |
| Orgenesis Inc. | 45.75 Million USD | -13873.818% |
| Entera Bio Ltd. | 8.86 Million USD | -72067.043% |
| GH Research PLC | 41.22 Million USD | -15411.135% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -24771.635% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -7598.698% |
| Xencor, Inc. | 306.97 Million USD | -1982.892% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -129500.945% |
| Replimune Group, Inc. | 234.77 Million USD | -2623.482% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -31105.637% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -3233.75% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -94925.361% |
| Portage Biotech Inc. | 18.19 Million USD | -35033.799% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -87977.4% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -5991.786% |
| OncoCyte Corporation | 25.63 Million USD | -24840.516% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -104795.214% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -55708.379% |
| Purple Biotech Ltd. | -22.46 Million USD | 28559.518% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -38698.544% |
| scPharmaceuticals Inc. | 65.17 Million USD | -9710.059% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -75544.146% |
| HilleVax, Inc. | 133.34 Million USD | -4695.08% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -62068.206% |
| Tharimmune, Inc. | 9.45 Million USD | -67524.021% |
| Genprex, Inc. | 31.06 Million USD | -20485.588% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -3309.661% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -20277.984% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -835716.993% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -117287.463% |
| OKYO Pharma Limited | 8243.57 USD | -77563382.811% |
| Savara Inc. | 15.74 Million USD | -40509.717% |
| Curis, Inc. | 58.35 Million USD | -10857.073% |
| Daré Bioscience, Inc. | 33.6 Million USD | -18924.438% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -125457.488% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -85598.968% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -23562.201% |
| BeiGene, Ltd. | 3.28 Billion USD | -94.548% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -31967.324% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -1181.966% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -4061.352% |
| Erasca, Inc. | 141.52 Million USD | -4417.93% |
| bluebird bio, Inc. | 240.23 Million USD | -2561.594% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -141142.251% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | -266.151% |
| DBV Technologies S.A. | 92.16 Million USD | -6837.934% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -141142.251% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -14906.219% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -44407.866% |
| Molecular Templates, Inc. | 63.09 Million USD | -10034.568% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -9486.063% |
| Travere Therapeutics, Inc. | 472 Million USD | -1254.655% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -4361.625% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -10199.282% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -14627.968% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -2972.118% |
| MacroGenics, Inc. | 217.21 Million USD | -2843.627% |
| RenovoRx, Inc. | 11.39 Million USD | -56007.406% |
| Adicet Bio, Inc. | 152.03 Million USD | -4105.528% |
| Prime Medicine, Inc. | 186.63 Million USD | -3325.865% |
| Aditxt, Inc. | 25.95 Million USD | -24538.965% |
| Adagene Inc. | 41.83 Million USD | -15185.184% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -87368.048% |
| Quantum-Si incorporated | 111.65 Million USD | -5626.363% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -3620.687% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -43761.31% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -17749.366% |
| SciSparc Ltd. | 9.01 Million USD | -70857.718% |
| Vericel Corporation | 142.04 Million USD | -4401.549% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -73762.171% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -27593.328% |
| Generation Bio Co. | 144.46 Million USD | -4325.924% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -7600.831% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -7295.327% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -2062.18% |
| Invivyd, Inc. | 205.75 Million USD | -3007.579% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -8760.988% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -68077.185% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -8396.558% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -62056.119% |
| 2seventy bio, Inc. | 289.88 Million USD | -2105.687% |
| ADMA Biologics, Inc. | 66.58 Million USD | -9502.619% |
| Clene Inc. | 41.07 Million USD | -15467.404% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -49822.368% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -11568.735% |
| GeoVax Labs, Inc. | 6.02 Million USD | -106074.3% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -1716.23% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -17307.157% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -18857.543% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -6065.744% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -19520.117% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -3655.036% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -732.856% |
| Evaxion Biotech A/S | 22.27 Million USD | -28611.271% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -4617.287% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -2622.218% |
| Trevena, Inc. | 38.41 Million USD | -16545.407% |
| Surrozen, Inc. | 18.55 Million USD | -34369.003% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -7897.999% |
| Cingulate Inc. | 22.75 Million USD | -27994.147% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 85444.367% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -14214.819% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -77554.188% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -6134.521% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -747.915% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -10200.609% |
| Clearmind Medicine Inc. | 8.74 Million USD | -73046.596% |
| Kronos Bio, Inc. | 128.11 Million USD | -4890.712% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -7505.386% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -217903.161% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -6241.555% |
| Statera Biopharma, Inc. | 28.82 Million USD | -22078.667% |
| ImmunityBio, Inc. | 362.87 Million USD | -1662.054% |
| Korro Bio, Inc. | 84.53 Million USD | -7463.82% |
| Kineta, Inc. | 21.15 Million USD | -30123.105% |
| BioVie Inc. | 31.95 Million USD | -19912.389% |
| Codexis, Inc. | 66.51 Million USD | -9512.436% |
| Celularity Inc. | 215.05 Million USD | -2873.151% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -2721.451% |
| Celcuity Inc. | 66.23 Million USD | -9554.187% |
| Virax Biolabs Group Limited | 6.54 Million USD | -97562.112% |
| Cibus, Inc. | 320.3 Million USD | -1896.222% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -14769.767% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -18792.566% |
| IN8bio, Inc. | 30.33 Million USD | -20976.573% |
| Kodiak Sciences Inc. | 277.32 Million USD | -2205.631% |
| Annexon, Inc. | 143.72 Million USD | -4348.836% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -4911.325% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -27810.428% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -998962.5% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -720.178% |
| Eyenovia, Inc. | 25.4 Million USD | -25066.842% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -4456.89% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -114858.648% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -7980.068% |
| Arcellx, Inc. | 200.19 Million USD | -3093.822% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -13830.283% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -2854.563% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -64116.129% |
| Moolec Science SA | 52.75 Million USD | -12021.188% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -10358.307% |
| Geron Corporation | 70.44 Million USD | -8977.1% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -13638.719% |
| Royalty Pharma plc | 862.4 Million USD | -641.416% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -6696.922% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -68447.297% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -28156.361% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -2976.819% |
| Humacyte, Inc. | 23.49 Million USD | -27111.985% |
| Structure Therapeutics Inc. | 102.77 Million USD | -6121.357% |
| 89bio, Inc. | 151.2 Million USD | -4128.724% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -7879.334% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -43875.241% |
| Genelux Corporation | 24.33 Million USD | -26174.913% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -18748.569% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -3598.755% |
| Notable Labs, Ltd. | 14.77 Million USD | -43190.454% |
| Liquidia Corporation | 87.98 Million USD | -7167.23% |
| Mustang Bio, Inc. | 48.5 Million USD | -13083.233% |
| Immunovant, Inc. | 282.7 Million USD | -2161.69% |
| Quantum-Si incorporated | 111.65 Million USD | -5626.363% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -28262.314% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -29965.359% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -6167.89% |
| Acasti Pharma Inc. | 11.3 Million USD | -56479.064% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -27795.688% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -39914.116% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -13638.129% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -563456.558% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -40149.276% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -21829.554% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -15350.416% |
| PepGen Inc. | 84.76 Million USD | -7443.119% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -21478.752% |
| United Therapeutics Corporation | 885.1 Million USD | -622.404% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -27825.056% |
| Solid Biosciences Inc. | 104.31 Million USD | -6029.512% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -19438.26% |
| Immuneering Corporation | 58.41 Million USD | -10846.215% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -125513.036% |
| Silo Pharma, Inc. | 3.92 Million USD | -162935.053% |
| Belite Bio, Inc | 31.66 Million USD | -20090.729% |
| XOMA Corporation | 46.46 Million USD | -13661.488% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -9365.581% |
| Bionomics Limited | 17.89 Billion USD | 64.264% |
| Apogee Therapeutics, Inc. | 93 Million USD | -6775.047% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 18020.404% |
| uniQure N.V. | 285.08 Million USD | -2142.832% |
| Cassava Sciences, Inc. | 105.95 Million USD | -5934.523% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -87368.048% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -3192.363% |
| Forte Biosciences, Inc. | 32.47 Million USD | -19587.78% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -76854.971% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -21651.999% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -114858.648% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -44896.481% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -71831.601% |
| Altimmune, Inc. | 30.55 Million USD | -20825.514% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -1395.144% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 18020.404% |
| Compugen Ltd. | 43.97 Million USD | -14441.402% |
| Peak Bio, Inc. | 1249.13 USD | -511876165.881% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -8526.552% |
| Benitec Biopharma Inc. | 22.38 Million USD | -28467.599% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -2529.231% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -22301.289% |
| Zura Bio Limited | 62.63 Million USD | -10107.861% |
| PolyPid Ltd. | 21.04 Million USD | -30282.514% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -39184.837% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -22301.289% |
| Instil Bio, Inc. | 85.78 Million USD | -7353.518% |
| argenx SE | 1.53 Billion USD | -316.947% |
| Immunome, Inc. | 122.82 Million USD | -5105.993% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -13090.849% |
| Verona Pharma plc | 67.15 Million USD | -9421.785% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -24601.565% |
| Shattuck Labs, Inc. | 93.61 Million USD | -6730.175% |
| CervoMed Inc. | 14.95 Million USD | -42647.022% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -8943.464% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -74736.142% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -12437.255% |
| Moolec Science SA | 52.75 Million USD | -12021.188% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -38772.987% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -4723.653% |
| AnaptysBio, Inc. | 181.56 Million USD | -3421.546% |
| Design Therapeutics, Inc. | 78.19 Million USD | -8077.516% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -7245.963% |
| NeurAxis, Inc. | 8.82 Million USD | -72384.477% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -50706.516% |
| Lumos Pharma, Inc. | 38.66 Million USD | -16436.92% |
| Achilles Therapeutics plc | 75.25 Million USD | -8396.445% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -24601.565% |
| 180 Life Sciences Corp. | 13.47 Million USD | -47342.033% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -24026.079% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -217903.161% |
| Nutriband Inc. | 5.73 Million USD | -111409.687% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -5671.8% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -11389.048% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -12467.071% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -9573.369% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -11713.811% |
| Palisade Bio, Inc. | 13.32 Million USD | -47903.003% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -13980.909% |
| Beam Therapeutics Inc. | 554.19 Million USD | -1053.748% |
| Neurogene Inc. | 55.58 Million USD | -11403.517% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -2473.152% |
| AEON Biopharma, Inc. | 48.42 Million USD | -13102.833% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -6511.519% |
| Sesen Bio, Inc. | 78.38 Million USD | -8057.589% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -7554.826% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -50698.863% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -1317.76% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -7175.003% |
| Athira Pharma, Inc. | 125.46 Million USD | -4996.201% |
| Vaccinex, Inc. | 23.45 Million USD | -27160.712% |
| HCW Biologics Inc. | 21.02 Million USD | -30307.77% |
| XOMA Corporation | 46.46 Million USD | -13661.488% |
| Nektar Therapeutics | 190.9 Million USD | -3249.345% |
| Arvinas, Inc. | 480 Million USD | -1232.083% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -281082.25% |
| Merus N.V. | 200.49 Million USD | -3089.123% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -6086.445% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -18369.093% |
| Rezolute, Inc. | 70.38 Million USD | -8984.064% |
| Clene Inc. | 41.07 Million USD | -15467.404% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -38939.046% |
| BeyondSpring Inc. | 24.86 Million USD | -25614.86% |
| Synlogic, Inc. | 58.53 Million USD | -10823.939% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -35636.642% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -142241.941% |
| Peak Bio, Inc. | 1249.13 USD | -511876165.881% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -10478.037% |
| Krystal Biotech, Inc. | 160.42 Million USD | -3885.638% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -2262.627% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -1737.156% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -296366.787% |
| MannKind Corporation | 125.59 Million USD | -4990.886% |
| Ikena Oncology, Inc. | 84.57 Million USD | -7459.975% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -66179.672% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -7036.081% |
| Gossamer Bio, Inc. | 183.75 Million USD | -3379.557% |
| CohBar, Inc. | 12.38 Million USD | -51513.228% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -12505.473% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -23081.785% |
| Legend Biotech Corporation | 583.14 Million USD | -996.468% |
| Mural Oncology plc | 192.07 Million USD | -3228.977% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -9422.391% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -39502.928% |
| Disc Medicine, Inc. | 91.12 Million USD | -6916.735% |
| Champions Oncology, Inc. | 28.11 Million USD | -22646.354% |
| REGENXBIO Inc. | 321.15 Million USD | -1890.927% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -119163.587% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -11367.824% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -16311.433% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -5491.262% |
| Vaxart, Inc. | 90.72 Million USD | -6947.594% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -74946.878% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -14841.318% |
| Cellectis S.A. | 97.32 Million USD | -6470.078% |
| Longeveron Inc. | 21.25 Million USD | -29989.412% |
| Repare Therapeutics Inc. | 167.35 Million USD | -3720.575% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | -369.865% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -8352.641% |
| Revolution Medicines, Inc. | 498.76 Million USD | -1181.966% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -96021.467% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -14447.026% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -8472.195% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -9082.164% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -57711.935% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | -33.906% |
| Denali Therapeutics Inc. | 527.23 Million USD | -1112.753% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -73762.171% |
| Veru Inc. | 101.34 Million USD | -6208.946% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -27216.615% |
| Cingulate Inc. | 22.75 Million USD | -27994.147% |
| Passage Bio, Inc. | 108.38 Million USD | -5799.123% |
| Context Therapeutics Inc. | 25.07 Million USD | -25401.926% |
| Exicure, Inc. | 14.07 Million USD | -45324.837% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -3002.919% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -14666.403% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -69571.984% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -2432.448% |
| Nuvalent, Inc. | 149.49 Million USD | -4177.152% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -79162.15% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -6068.837% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -29710.248% |
| OmniAb, Inc. | 83.89 Million USD | -7521.432% |
| Anew Medical, Inc. | 1.3 Million USD | -491428.173% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -19415.322% |
| Lipocine Inc. | 15.08 Million USD | -42300.14% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -9232.535% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -8296.365% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -15760.373% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -5467.601% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -28465.046% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -862.742% |
| Ocugen, Inc. | 71.56 Million USD | -8834.285% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -6711.838% |
| Q32 Bio Inc. | 92.68 Million USD | -6799.007% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -30097.412% |
| Alumis Inc. Common Stock | 158.17 Million USD | -3942.384% |
| Equillium, Inc. | 50.6 Million USD | -12534.865% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -10145.81% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -45881.624% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -33793.259% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -13518.453% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -5794.935% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -51494.778% |
| Dominari Holdings Inc. | 23.83 Million USD | -26726.096% |
| Edesa Biotech, Inc. | 9.22 Million USD | -69228.502% |
| vTv Therapeutics Inc. | 11.9 Million USD | -53599.504% |
| Bio-Techne Corporation | 563.03 Million USD | -1035.623% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -1464.067% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -2279.11% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -4733.796% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -44268.885% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -3806.021% |
| Nkarta, Inc. | 131.65 Million USD | -4756.817% |
| BioCardia, Inc. | 12.12 Million USD | -52651.423% |
| Iterum Therapeutics plc | 47.46 Million USD | -13370.127% |